Plain-English translation of NCT07344363 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Prostate Cancer research guide →Researchers are testing a new way to collect and measure blood samples from people taking prostate cancer medications like abiraterone, apalutamide, darolutamide, or enzalutamide. Instead of traditional blood draws, they want to see if a tiny drop of blood dried on a special card works just as well for checking how much medication is in your body. If it works, this simpler method could make it easier for patients to have their medication levels monitored regularly.
Currently, checking medication levels requires traditional blood draws, which can be inconvenient and burdensome for patients. This study aims to prove that a simpler dried blood spot method is just as accurate, which could make it easier for doctors to monitor whether your medication is working properly without frequent hospital visits.
You likely qualify if…
You likely don't qualify if…
You will donate blood samples that will be collected using both the traditional method and the new dried blood spot method. Your samples will then be analyzed in the laboratory using specialized equipment to compare how well the two methods match. The study does not involve taking any new medications—you will continue your current prostate cancer treatment as usual.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Italy